2020-11-12T12:33:30-06:00 2019-12-31 Grant Thornton LLP 100 E Wisconsin Ave Milwaukee WI 53202 990 2019-01-01 350991629 Versiti Indiana Inc % DEBRA QUALKENBUSH VERS 3179165010 3450 North Meridian Street Indianapolis IN 46208 CHRIS MISKEL CEO 3179165010 2020-11-12 true Michelle L Weber P00556798 4142898200 65.26.236.111 39529020203175000005 2020-11-12 P 9B78095357A78499D8286BCD82111F39E51840A5 6098D55FF0E7CCF9C3E403A7CE8C578524A243B8 2019 2021-01-29 14:40:06Z Chris Miskel 638 N 18th Street Milwaukee WI 532332121 75968226 false X www.versiti.org X 1952 IN TO PROVIDE A CONTINUOUS, SAFE, AND ADEQUATE SUPPLY OF BLOOD PRODUCTS AND TESTING SERVICES FIRST TO OUR OWN COMMUNITIES, THEN WHEREVER OUR PRODUCTS AND SERVICES ARE NEEDED. 10 9 572 9 0 0 32624 22067 67413846 75029441 565093 562813 52797 119936 68064360 75734257 33200 54690 0 0 23897228 24873700 0 0 0 41487810 51192509 65418238 76120899 2646122 -386642 44700229 45507285 8066515 7274959 36633714 38232326 X STEWARDS OF INDIANA'S BLOOD SUPPLY, LINKING VOLUNTEER DONORS TO HOOSIER PATIENTS IN NEED BY RECRUITING, COLLECTING, PROCESSING, TESTING, LABELING AND DISTRIBUTING BLOOD TO HOSPITALS EVERY DAY. A COMMUNITY BLOOD PROGRAM, SUPPLYING FIRST IN INDIANA THEN WHEREVER THE LIFE-SAVING RESOURCE IS NEEDED. false false 63563471 59957 71023834 THE BLOOD BANKING UNIT HAS ACCOMPLISHED A CONTINUOUS, SAFE, AND ADEQUATE SUPPLY OF BLOOD PRODUCTS BY EDUCATING AND RECRUITING BLOOD DONORS, PROVIDING ACCESSIBLE DONATION SITES, ENSURING A HEALTHY DONOR IS DRAWN, AND TESTING DONATIONS FOR VIRAL MARKERS. IN THE YEAR ENDED 2019, 130,750 PRODUCTIVE UNITS OF BLOOD WERE COLLECTED. 2349390 4026432 THE TESTING UNIT PROVIDES A SAFE SUPPLY OF BLOOD PRODUCTS BY STRICT ADHERENCE TO THE FDA, CLIA, AABB, OSHA, GMP, ETC. GUIDELINES TO RELEASE A COMPLETELY SAFE PRODUCT. ON AN ON-GOING BASIS THE UNIT UPDATES REAGENTS USED TO PERFORM TESTS FOR VIRAL MARKERS. 65912861 true false false false false false false false false true true false false false true true false true false false false false false false false false false true true true false false false false false false false false false false false false false true false false false true 0 0 true 572 true false false false false false false false false false false false false X 10 9 false false false false true true true true true false false true true true true true true true true false IN X DEBRA QUALKENBUSH 3179165010 3450 N MERIDIAN STREET INDIANAPOLIS IN 46208 X Chris Miskel CEO 10.0 45.0 X 165170 752436 41657 Thomas Abshire MD EVP MSI & Chief Med Officer 0.0 55.0 X 0 577401 24817 Brian Bautista EVP & CHIEF OPERATING OFFICER 10.0 45.0 X 99242 452104 41657 Gilbert C White MD EVP of Research-thru 6/19 0.0 55.0 X 0 500655 37934 Gitesh Dubal EVP & Chief Marketing Officer 10.0 45.0 X 85418 389130 41657 Anthony Watkins EVP & Chief Financial Officer 10.0 45.0 X 85337 388754 40559 James Weidner EVP & Chief HR Officer 10.0 45.0 X 69840 318160 41551 Dan Waxman MD EVP & Chief Medical Officer 55.0 0.0 X 368974 0 26007 Lynne Briggs VP & Chief Information Officer 10.0 45.0 X 60040 273516 44457 Charles Miraglia MD President - thru 11/19 55.0 0.0 X X 344325 0 25440 Bart Reuter EVP & Gen. Counsel-As Of 1/19 10.0 45.0 X 57061 259942 40545 Bradley Pietz EVP & CHIEF INNOVATION OFFICER 10.0 45.0 X 55248 251687 25901 Margaret McElligott VP & Chief Quality Officer 10.0 45.0 X 51342 233897 36791 Julie Cruz MD Assistant Medical Director 55.0 0.0 X 302078 0 18176 Maureen Kwiecinski Former EVP & Gen. Counsel 0.0 0.0 X 52992 241410 729 Colleen McCarthy Chief of Staff & VP Organ Don. 10.0 45.0 X 45625 207844 38262 Lora Poore VP Laboratory Services 55.0 0.0 X 232206 0 21987 Jennifer L White Director Clinical Services 55.0 0.0 X 153374 0 18714 Damon Clements Assistant Medical Director 55.0 0.0 X 129234 0 22246 Debra Qualkenbush Director Accounting 55.0 0.0 X 124851 0 12841 Beth Hughes Director QA 55.0 0.0 X 127350 0 6859 Gregory N Larkin MD Chair 1.0 4.0 X X 0 0 0 L Alan Whaley Director 1.0 4.0 X 0 0 0 Nancy Ahlrichs Vice Chair 1.0 0.0 X X 0 0 0 James F Austin Director 1.0 0.0 X 0 0 0 E Randall Wright Director 1.0 0.0 X 0 0 0 Connie Danielson MD Secretary 1.0 0.0 X X 0 0 0 John Myrland Treasurer 1.0 0.0 X X 0 0 0 Timothy P Robinson J Director 1.0 0.0 X 0 0 0 James L Rice Director 1.0 0.0 X 0 0 0 Amy Shapiro Director 1.0 0.0 X 0 0 0 2609707 4846936 608787 14 true true false MEDSPEED LLC 655 WEST GRAND AVENUE ELMHURST IL 60126 DELIVERY SERVICES 1237991 BLUELINE SECURITY 2302 E TROY AVE INDIANAPOLIS IN 46203 HQ SECURITY SERVICES 147522 CITY WIDE MAINTENANCE INDIANAPOLIS 5155 N SHADELAND AVE STE 300 INDIANAPOLIS IN 46226 CLEANING SERVICES 146962 INCEPT CORPORATION 4150 BELDEN VILLAGE ST NW STE 205 CANTON OH 44718 CALL CENTER SERVICES 101745 4 22067 22067 BLOOD SERVICES 900099 44470983 44470983 0 0 DONOR TESTING LABORATORY 621500 26129085 26129085 0 0 DIAGNOSTIC LABORATORIES 621500 4026432 4026432 0 0 MEDICAL SERVICES 962150 402941 402941 0 0 75029441 543845 543845 0 0 0 0 0 233343 19594 233969 -626 19594 18968 18968 0 0 0 0 0 0 0 0 0 PATRONAGE DIVIDENDS 900099 84207 84207 RESEARCH INCOME 900099 20825 20825 MISCELLANEOUS 900099 14904 14904 119936 75734257 75050266 0 661924 25090 25090 29600 29600 0 0 1864009 1584408 279601 0 17656301 14955612 2700689 925288 781993 143295 3108685 2627877 480808 1319417 1115503 203914 0 11302 2275 9027 18257 18257 0 0 788 0 788 2645503 2344626 300877 203477 62765 140712 302171 250607 51564 802649 544520 258129 0 1623407 668820 954587 1125208 1065240 59968 0 11176 10627 549 0 0 1280756 526622 754134 206214 70379 135835 MEDICAL LAB SUPPLIES 28116155 28116155 0 0 COST OF IMPORTED PRODUCTS 8698956 8698956 0 0 VERSITI SERVICES ALLOCATION 4098630 621722 3476908 0 EQUIPMENT LEASE/MAINTENANCE 1098119 900185 197934 0 949741 909279 40462 76120899 65912861 10208038 0 0 368663 7254557 0 0 0 9614787 16062648 0 0 0 0 0 0 3664190 2596389 834779 404754 36262060 28627489 7557615 7634571 15497547 18196596 0 0 0 0 0 0 276754 243664 44700229 45507285 7706007 6963859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 360508 311100 8066515 7274959 X 36158678 37754042 475036 478284 36633714 38232326 44700229 45507285 X -386642 2016466 -31212 X false true X true false X 345250 61621 40971 32624 22067 502533 50299398 60016732 67246177 67413846 75050266 320026419 0 0 0 50644648 60078353 67287148 67446470 75072333 320528952 0 26560237 33404428 40111391 39237398 43177371 182490825 26560237 33404428 40111391 39237398 43177371 182490825 138038127 422179 378163 485008 490460 543845 2319655 0 422179 378163 485008 490460 543845 2319655 0 0 0 57243 52797 99111 209151 51066827 60456516 67829399 67989727 75715289 323057758 0.42729 0.43105 0.00718 0.00723 X 60355 60355 60313 42 60355 60267 46 60313 60217 50 60267 60107 110 60217 1.00000 false false 1380724 1380724 17815054 13947818 3867236 854108 535170 318938 129911200 11141601 1849599 3220974 3002900 218074 7634571 0 LONG TERM RETIREMENT LIABILITIES 189743 NH LEASE OBLIGATION 110336 SUBLESSEE SECURITY DEPOSIT 11021 311100 X 77730341 2016466 2016466 75713875 788 19594 20382 75734257 76131729 11618 11618 76120111 788 788 76120899 PART V ENDOWMENTS THE INTENDED USE OF THE ORGANIZATION'S ENDOWMENT FUNDS IS TO PERPETUATE THE MISSION OF VERSITI INDIANA, INC. ADDITIONALLY, THE FILING ORGANIZATION IS A BENEFICIARY OF THE VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION'S ("VBRIF") ENDOWMENT AS A SUPPORTED ORGANIZATION. THE VBRIF BOARD DESIGNATED ENDOWMENT FUNDS ARE DESIGNATED BY THE BOARD AS ENDOWMENT FUNDS TO ENSURE THE CONTINUING AVAILABILITY OF FUNDS FOR RESEARCH PURPOSES. THE AMOUNT OF THE VBRIF TOTAL ENDOWMENT AS OF 12/31/2019 WAS $87,979,140 AND WAS ALL BOARD RESTRICTED. Part X INCOME TAXES VERSITI, WISCONSIN, ILLINOIS, MICHIGAN, INDIANA AND THE FOUNDATION HAVE ALL RECEIVED TAX DETERMINATION LETTERS CONFIRMING THAT THE ORGANIZATIONS QUALIFY AS TAX-EXEMPT ORGANIZATIONS UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). THE ORGANIZATION FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS MORE LIKELY THAN NOT TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. VERSITI, WISCONSIN, ILLINOIS, MICHIGAN, INDIANA AND THE FOUNDATION ARE EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3), THOUGH THEY ARE SUBJECT TO TAX ON INCOME UNRELATED TO THEIR EXEMPT PURPOSES, UNLESS THAT INCOME IS OTHERWISE EXCLUDED BY THE IRC. THE ORGANIZATION HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX-EXEMPT STATUS; TO IDENTIFY AND REPORT UNRELATED INCOME; TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT HAS NEXUS; AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. WISCONSIN AND THE FOUNDATION HAVE FILED FEDERAL AND STATE OF WISCONSIN INCOME TAX RETURNS TO REPORT UNRELATED BUSINESS INCOME THROUGH 2009 AND ARE NO LONGER SUBJECT TO TAX AUTHORITY EXAMINATIONS FOR YEARS PRIOR TO 2010 UNDER THE FEDERAL AND STATE STATUTE. MANAGEMENT HAS DETERMINED THAT THERE IS NO UNRELATED BUSINESS INCOME TO REPORT FOR WISCONSIN FOR 2010 THROUGH 2017, AND INCOME TAX RETURNS ARE NOT REQUIRED TO BE FILED; HOWEVER INCOME TAX RETURNS WERE FILED FOR 2018. THEREFORE, AS THE STATUTE OF LIMITATIONS WILL REMAIN OPEN FOR RETURNS NOT FILED, TAX YEARS 2010 THROUGH 2017, WILL REMAIN OPEN TO AUDIT FOR BOTH FEDERAL AND STATE PURPOSES. MANAGEMENT HAS DETERMINED THAT THE FOUNDATION WILL BE FILING INCOME TAX RETURNS FOR TAX YEARS 2016 AND 2017. THEREFORE, AS THE STATUTE OF LIMITATIONS WILL REMAIN OPEN FOR RETURNS NOT FILED, TAX YEARS 2010 THROUGH 2015, WILL REMAIN OPEN TO AUDIT FOR BOTH FEDERAL AND STATE PURPOSES. MICHIGAN HAS NOT HISTORICALLY FILED ANY UNRELATED BUSINESS INCOME TAX RETURNS; THEREFORE, TAX YEARS REMAIN OPEN FOR YEARS IN WHICH AN INCOME TAX RETURN HAS NOT BEEN FILED; HOWEVER INCOME TAX RETURNS WERE FILED FOR 2018 BUT ARE NOT EXPECTED TO BE FILED FOR 2019. IN YEARS PRIOR TO 2014, ILLINOIS FILED BOTH FEDERAL AND STATE OF ILLINOIS INCOME TAX RETURNS TO REPORT A ZERO AMOUNT OF UNRELATED BUSINESS INCOME. MANAGEMENT HAS DETERMINED THAT THERE IS NO UNRELATED BUSINESS INCOME TO REPORT FOR ILLINOIS FOR TAX YEARS 2014 THROUGH 2017; HOWEVER INCOME TAX RETURNS WERE FILED FOR 2018 BUT ARE NOT EXPECTED TO BE FILED FOR 2019. THEREFORE, AS THE STATUTE OF LIMITATIONS WILL REMAIN OPEN FOR RETURNS NOT FILED, TAX YEARS 2014 THROUGH 2017, WILL REMAIN OPEN TO AUDIT FOR BOTH FEDERAL AND STATE PURPOSES. IN YEARS PRIOR TO 2014, INDIANA FILED FEDERAL UNRELATED BUSINESS INCOME TAX RETURNS TO REPORT A ZERO AMOUNT OF UNRELATED BUSINESS INCOME. IN 2014 THROUGH 2016, INDIANA FILED FEDERAL AND INDIANA RETURNS TO REPORT AN UNRELATED BUSINESS LOSS. IN 2017 AND 2018, INDIANA FILED INCOME TAX RETURNS TO REPORT A ZERO AMOUNT OF UNRELATED BUSINESS INCOME IN ORDER TO MAINTAIN THE PRIOR YEAR NET OPERATING LOSS. INDIANA IS EXPECTED TO FILE INCOME TAX RETURNS FOR 2019. THE STATUTE OF LIMITATIONS WILL REMAIN OPEN FOR BOTH FEDERAL AND STATE PURPOSES FOR ANY RETURNS NOT FILED. VERSITI HAS NOT FILED ANY UNRELATED BUSINESS INCOME TAX RETURNS; THEREFORE THE YEARS SINCE 2012, THE YEAR OF INCEPTION, ARE STILL OPEN TO EXAMINATION. THE ORGANIZATION HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. SALUS HAS BEEN ORGANIZED AS A LIMITED LIABILITY COMPANY AND, ACCORDINGLY, IS NOT SUBJECT TO FEDERAL OR STATE INCOME TAXES. ALL INCOME TAX ATTRIBUTES OF THE ENTITY ARE PASSED THROUGH TO ITS SOLE MEMBER, WISCONSIN. THE ENTITY IS INCLUDED IN THE CONSOLIDATED INFORMATION RETURN FILED BY VERSITI. CENETRON IS FORMED AS A LIMITED LIABILITY COMPANY AND HAS ELECTED TO BE TREATED AS A WHOLLY OWNED LLC THAT HAS ELECTED TO BE TREATED AS A C-CORPORATION FOR TAX PURPOSES AND SO IS SUBJECT TO FEDERAL AND STATE INCOME TAXES. INCOME TAXES ARE PROVIDED FOR THE TAX EFFECTS OF TRANSACTIONS REPORTED BY CENETRON AND CONSIST OF TAXES CURRENTLY DUE AND DEFERRED TAXES. DEFERRED TAXES ARE RECOGNIZED FOR DIFFERENCES BETWEEN THE BASIS OF ASSETS AND LIABILITIES FOR FINANCIAL STATEMENT AND INCOME TAX PURPOSES. THE DIFFERENCES RELATED PRIMARILY TO INVENTORY, PROPERTY AND EQUIPMENT, INTANGIBLE ASSETS AND ACCRUED LIABILITIES. THE DEFERRED TAX ASSETS AND LIABILITIES REPRESENT THE FUTURE TAX RETURN CONSEQUENCES OF THOSE DIFFERENCES, WHICH WILL EITHER BE TAXABLE OR DEDUCTIBLE WHEN THE ASSETS AND LIABILITIES ARE RECOVERED OR SETTLED. CENETRON IS SUBJECT TO TAXATION IN THE UNITED STATES AND VARIOUS CERTAIN, LIMITED STATE JURISDICTIONS. THE ORGANIZATION RECOGNIZES, IF NECESSARY, INTEREST AND PENALTIES RELATED TO UNRECOGNIZED TAX BENEFITS IN THE PROVISION FOR INCOME TAXES. THERE WERE NO INTEREST OR PENALTIES RELATED TO INCOME TAXES THAT HAVE BEEN ACCRUED OR RECOGNIZED AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2019 AND 2018. PART XI, LINE 4B RECONCILIATION OF REVENUE GAIN ON ASSET SALE $19,594 PART XII, LINE 2D RECONCILIATION OF EXPENSES GAIN ON ASSET SALE $(19,594) BAD DEBT RESERVE ADJUSTMENT 31,212 ------- TOTAL 11,618 true Community Health Network Foundation Inc 7240 Shadeland Station Suite 125 Indianapolis IN 46256 510181688 501(c)(3) 10000 General Support Community Health Network Foundation Inc 7240 Shadeland Station Suite 125 Indianapolis IN 46256 510181688 501(c)(3) 10000 Giving Gig Spshp 1 SCHOLARSHIPS 74 29600 0 PART I, LINE 2 GRANTS THE FILING ORGANIZATION OFFERS SCHOLARSHIPS TO HIGH SCHOOL SENIORS IF CERTAIN CRITERIA ARE MET. THE SCHOLARSHIPS ARE SENT TO THE COLLEGE OR UNIVERSITY WHERE THE STUDENT IS ENROLLED. X true true X X X X true false false false true false true true false Charles Miraglia MD President - thru 11/19 272458 0 37742 0 34125 0 11200 0 14240 0 369765 0 0 0 Dan Waxman MD EVP & Chief Medical Officer 324585 0 27459 0 16930 0 11200 0 14807 0 394981 0 0 0 Lora Poore VP Laboratory Services 203502 0 26492 0 2212 0 6865 0 15122 0 254193 0 0 0 Chris Miskel CEO 114370 521016 50580 230420 220 1000 3528 16072 3970 18087 172668 786595 0 0 Brian Bautista EVP & CHIEF OPERATING OFFICER 76462 348327 22523 102604 257 1173 3528 16072 3970 18087 106740 486263 0 0 James Weidner EVP & Chief HR Officer 52256 238055 16972 77317 612 2788 3509 15985 3970 18087 77319 352232 0 0 Gitesh Dubal EVP & Chief Marketing Officer 62626 285298 22641 103143 151 689 3528 16072 3970 18087 92916 423289 0 0 Lynne Briggs VP & Chief Information Officer 49716 226484 9716 44263 608 2769 4032 18368 3970 18087 68042 309971 0 0 Anthony Watkins EVP & Chief Financial Officer 70767 322383 13795 62843 775 3528 3528 16072 3773 17186 92638 422012 0 0 Margaret McElligott VP & Chief Quality Officer 42998 195882 7226 32919 1118 5096 3837 17482 2785 12687 57964 264066 0 0 Gilbert C White MD EVP of Research-thru 6/19 0 412806 0 82238 0 5611 0 22400 0 15534 0 538589 0 0 Thomas Abshire MD EVP MSI & Chief Med Officer 0 486567 0 84012 0 6822 0 22400 0 2417 0 602218 0 0 Bradley Pietz EVP & CHIEF INNOVATION OFFICER 49559 225767 5407 24634 282 1286 3098 14114 1564 7125 59910 272926 0 0 Julie Cruz MD Assistant Medical Director 278777 0 21853 0 1448 0 10063 0 8113 0 320254 0 0 0 Damon Clements Assistant Medical Director 128269 0 250 0 715 0 0 0 22246 0 151480 0 0 0 Maureen Kwiecinski Former EVP & Gen. Counsel 0 0 6106 27817 46886 213593 0 0 131 598 53123 242008 0 0 Jennifer L White Director Clinical Services 137078 0 15641 0 655 0 4773 0 13941 0 172088 0 0 0 Bart Reuter EVP & Gen. Counsel-As Of 1/19 56777 258650 0 0 284 1292 3504 15965 3794 17282 64359 293189 0 0 Colleen McCarthy Chief of Staff & VP Organ Don. 40505 184522 4978 22676 142 646 2917 13288 3970 18087 52512 239219 0 0 PART I, Line 1A CHARTER TRAVEL VERSITI INDIANA CHARTERED AN AIRPLANE FOR TWO OF ITS OFFICERS, CHRIS MISKEL AND BART REUTER, FOR THE 2019 BOARD MEETING. THE CHARTERED TRAVEL EXPENSES ARE NOT TREATED AS TAXABLE COMPENSATION. PART I, LINE 4A SEVERANCE PAYMENTS AN INDIVIDUAL LEFT THE ORGANIZATION IN 2018. THE INDIVIDUAL RECEIVED SEVERANCE IN 2019, WHICH IS INCLUDED ON SCHEDULE J, PART II. DUE TO A CONFIDENTIALITY AGREEMENT, NEITHER THE NAME NOR THE AMOUNT WILL BE LISTED. PART I, LINES 5B, 6B AND 7 NON-FIXED PAYMENTS INCENTIVE PAYOUT OPPORTUNITIES, BASED ON PERCENTAGE OF BASE PAY RATE, ARE AVAILABLE TO CERTAIN EMPLOYEES OF THE FILING ORGANIZATION. WHILE LEVELS OF THE INCENTIVE PAYOUT OPPORTUNITY ARE FIXED AND DETERMINED PERCENTAGES OF BASE COMPENSATION; THE INCENTIVE PAYOUT IS DETERMINED; IN PART, ON THE CONSOLIDATED REVENUE AND NET EARNINGS OF OPERATING DIVISIONS. THE INCENTIVE PAYOUT IS SUBJECT TO THE REVIEW OF ACCOMPLISHMENTS / OBJECTIVES AND THE ULTIMATE DETERMINATION OF INCENTIVE COMPENSATION IS SUBJECT TO PRESIDENT / CEO AND EXECUTIVE COMMITTEE OF THE BOARD APPROVAL. PART VI, SECTION A, LINE 6 MEMBERS OR STOCKHOLDERS VERSITI, INC. (A 501(C)(3) ORGANIZATION) IS THE SOLE VOTING MEMBER. PART VI, SECTION A, LINES 7A AND 7B MEMBER OR STOCKHOLDER POWERS VERSITI, INC. HAS RESERVE POWERS; INCLUDING THE ABILITY TO ELECT A MAJORITY OF DIRECTORS. PART VI, SECTION B, LINE 11B FORM 990 REVIEW VERSITI INDIANA UTILIZES GRANT THORNTON LLP TO COMPLETE THE IRS FORM 990 AND RELATED SCHEDULES. FOLLOWING COMPLETION, THEY ARE REVIEWED BY THE CONTROLLER AND CEO OF VERSITI. THE DRAFT FORMS ARE THEN REVIEWED BY THE COMPLIANCE AND AUDIT COMMITTEE PRIOR TO SUBMISSION TO THE IRS. THE FULL BOARD IS PROVIDED A COPY OF THE FORM 990 PRIOR TO FILING. PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST POLICY VERSITI INDIANA MAINTAINS A WRITTEN CONFLICT OF INTEREST POLICY. ON AN ANNUAL BASIS, CURRENT DIRECTORS AND OFFICERS ARE ASKED TO COMPLETE A DISCLOSURE FORM BASED ON IRS REQUIREMENTS THAT INCLUDES THE FOLLOWING: WHETHER THEY HAVE ANY DIRECT OR INDIRECT RELATIONSHIP EITHER THROUGH BUSINESS OR FAMILY MEMBER WITH THE ORGANIZATION. WHETHER THEY RECEIVED COMPENSATION FROM ANY ORGANIZATION THAT SHARES COMMON OWNERSHIP OR CONTROL WITH THE ORGANIZATION. WHETHER THEY HAVE SERVED AS AN OFFICER, DIRECTOR, KEY EMPLOYEE, PARTNER OR MEMBER OF AN ENTITY (OR SHAREHOLDER OF A PROFESSIONAL CORPORATION) DOING BUSINESS WITH THE ORGANIZATION. THESE ANSWERS ARE ACCUMULATED, SUMMARIZED AND EVALUATED BY MANAGEMENT TO DETERMINE IF ANY CONFLICTS EXIST. IDENTIFIED CONFLICTS ARE ADDRESSED IN ACCORDANCE WITH THE WRITTEN POLICY. PART VI, SECTION B, LINES 15A AND 15B COMPENSATION PROCESS THE COMPENSATION COMMITTEE OF THE VERSITI BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR VERSITI AND THE RELATED ENTITIES THAT IT SUPPORTS, INCLUDING VERSITI INDIANA. OTHER THAN THE VERSITI PRESIDENT & CHIEF EXECUTIVE OFFICER, THE COMPENSATION COMMITTEE DOES NOT INCLUDE MEMBERS OF MANAGEMENT AND IS COMPRISED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITH RESPECT TO VERSITI OR VERSITI INDIANA COMPENSATION ARRANGEMENTS. THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER RECUSES HER/HIMSELF FROM ALL DISCUSSIONS AND APPROVALS RELATED TO HER/HIS COMPENSATION. THE VERSITI COMPENSATION COMMITTEE REVIEWS VERSITI INDIANA EXECUTIVE COMPENSATION ARRANGEMENTS TO ENSURE SUCH ARRANGEMENTS ARE FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO SIMILARLY-SITUATED EXECUTIVES. EXECUTIVE COMPENSATION ARRANGEMENTS ARE REVIEWED FOR REASONABLENESS AND APPROVED BY THE COMPENSATION COMMITTEE ANNUALLY IN ACCORDANCE WITH THE VERSITI REASONABLENESS REVIEW POLICY. THE COMPENSATION COMMITTEE ASSESSES THE REASONABLENESS OF EXECUTIVE COMPENSATION ARRANGEMENTS AFTER IT OBTAINS AND REVIEWS APPROPRIATE DATA FOR COMPARABILITY FROM THE HUMAN RESOURCE DEPARTMENT AND AN INDEPENDENT COMPENSATION CONSULTANT. THE COMPENSATION COMMITTEE ENGAGES A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT ANNUALLY. THE INDEPENDENT CONSULTANT PERFORMS AN ANALYSIS OF COMPENSATION LEVELS AT REGIONAL AND NATIONAL ORGANIZATIONS OF COMPARABLE SIZE, SCOPE AND STRUCTURE AND PROVIDES THE COMMITTEE WITH COMPREHENSIVE DATA ON THE AVAILABILITY OF SIMILAR SERVICES WITHIN THE GEOGRAPHIC AREA, COMPENSATION SURVEYS, WRITTEN OFFERS FROM SIMILAR INSTITUTIONS, AND OTHER INFORMATION RELEVANT TO COMPARABILITY OF COMPENSATION. THE COMPENSATION COMMITTEE'S REVIEW, RECOMMENDATIONS AND APPROVALS ARE DOCUMENTED CONCURRENTLY IN THE COMMITTEE MINUTES, WHICH ARE SUBSEQUENTLY REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE AS REASONABLE, ACCURATE AND COMPLETE. VERSITI AND VERSITI INDIANA HAVE INCENTIVE PROGRAMS FOR THE CHIEF EXECUTIVE OFFICER AND OTHER CORPORATE OFFICERS DESCRIBED IN DETAILED WRITTEN POLICIES APPROVED BY THE COMPENSATION COMMITTEE ANNUALLY. EVALUATION AND COMPENSATION REVIEW -CEO - EACH YEAR, THE EXECUTIVE/COMPENSATION COMMITTEE EVALUATES THE VERSITI/VERSITI INDIANA CEO'S PERFORMANCE AGAINST ESTABLISHED OBJECTIVES, DETERMINES INCENTIVE PAYMENT AND MERIT INCREASE BASED UPON PERFORMANCE AND MARKET DATA PROVIDED BY THE THIRD PARTY COMPENSATION CONSULTANT, AND WORKS WITH THE CEO TO ESTABLISH OBJECTIVES FOR THE NEXT YEAR. -OTHER CORPORATE OFFICERS - EACH YEAR, THE VERSITI/VERSITI INDIANA CEO REVIEWS THE PERFORMANCE AND THE ACHIEVEMENT OF INDIVIDUAL GOALS AND OBJECTIVES OF EACH VERSITI/VERSITI INDIANA CORPORATE OFFICER. THE VERSITI/VERSITI INDIANA CEO PRESENTS HIS/HER RECOMMENDATIONS TO THE COMPENSATION COMMITTEE, WHICH REVIEWS AND APPROVES RECOMMENDED COMPENSATION RANGES, AND APPROVES FINAL SALARY AND INCENTIVE PAYMENTS. CORPORATE OFFICERS ARE POSITIONED WITHIN THE APPROPRIATE SALARY RANGE BASED UPON: -EXECUTIVE'S KNOWLEDGE, COMPETENCIES, AND EXPERIENCE, -PERFORMANCE OF THE EXECUTIVE'S AREAS OF RESPONSIBILITY, -THE EXECUTIVE'S CONTRIBUTION TO OVERALL PERFORMANCE, -THE IMPORTANCE OF RETAINING THE EXECUTIVE, -INTERNAL EQUITY CONSIDERATIONS, -THE FINANCIAL RESOURCES AVAILABLE, AND -EXECUTIVE BASE SALARY INCREASES IN THE COMPETITIVE MARKET PART VI, SECTION C, LINE 19 ORGANIZATION'S DOCUMENTS OPEN TO THE PUBLIC THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST DURING NORMAL BUSINESS HORUS AND AT THE ORGANIZATION'S LOCATION. PART VII AVERAGE Hours THE HOURS LISTED ON FORM 990, PART VII ARE REPRESENTATIVE OF AN AVERAGE FOR THE OFFICERS AND EXECUTIVE TEAM. EACH INDIVIDUAL PERSON'S WEEKLY TALLY MAY BE GREATER OR LESSER PER WEEK BASED ON THEIR INDIVIDUAL ROLES AND RESPONSIBILITIES WITHIN THE FILING ORGANIZATION AND RELATED PARTIES. PART XI, LINE 9 OTHER CHANGES IN NET ASSETS BAD DEBT RESERVE ADJUSTMENT ($31,212) VERSITI INC PO BOX 2178 638 N 18TH ST MILWAUKEE WI 53201 454675354 SUPPORTING WI 501(C)(3) 12B NA false VERSITI WISCONSIN INC PO BOX 2178 638 N 18TH ST MILWAUKEE WI 53201 390807235 BLOOD WI 501(C)(3) 07 VERSITI false VERSITI MICHIGAN INC PO BOX 1704 GRAND RAPIDS MI 49501 381550001 BLOOD MI 501(C)(3) 10 VERSITI false VERSITI BLOOD RESEARCH INSTITUTE FNDN PO BOX 2178 638 N 18TH ST MILWAUKEE WI 53201 391372542 SUPPORTING WI 501(C)(3) 12B VERSITI false VERSITI ILLINOIS INC 1200 N HIGHLAND AVE AURORA IL 60506 362179768 BLOOD IL 501(C)(3) 10 VERSITI false false false false false false false true true false false false true true false true true true false false